Evidence map›Paper›PMID 36161116›Full record

ArticlePreventive medicine reports2022

The impact of offering multiple cervical screening options to women whose screening was overdue in Dumfries and Galloway, Scotland.

L Wedisinghe, P Sasieni, H Currie, G Baxter

Abstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

L WedisingheDepartment of Obstetrics and Gyanecology, Central Queensland Hospital and Health Service, Rockhampton, QLD 4700, Australia.
P SasieniSchool of Cancer and Pharmaceutical Sciences, King's College London, Great Maze Pond, London SE1 9RT, United Kingdom.
H CurrieNHS Dumfries and Galloway, Dumfries and Galloway Royal Infirmary, Dumfries DG2 8RX, United Kingdom.
G BaxterNHS Dumfries and Galloway, Dumfries and Galloway Royal Infirmary, Dumfries DG2 8RX, United Kingdom.

Funding

Cancer Research UK 16893Cancer Research UK 25356
6 · The paper itself

Abstract

Most women who develop cancer have not been screened regularly. One in four women in Scotland, is overdue for cervical screening. Aim was to assess the impact of offering multiple cervical screening options to women whose screening is overdue. A prospective cohort study including all women whose screening was overdue, aged 30-60 years in Dumfries and Galloway in 2012. Potentially eligible women (n = 4146) were identified split into six groups. Women aged 30-55 years were allocated to three different groups. Group 1 (letter, n = 1246), Group 2 (letter and kit, n = 221), Group 3 (letter, n = 2031). Women aged 56-60 years were allocated to: Group 4 (letter, n = 292), Group 5 (letter and kit, n = 292) and Group 6 (control, n = 64). Women who self-collected a vaginal sample were requested to complete a questionnaire. The percentages of women responding were 24 % (21-26), 32 % (25-38), 16 % (14-18), 15 % (11-20) and 12 % (9-17) in groups 1 to 5 respectively, compared with 3 % (0-11) among controls. A significantly higher number of women (n = 383, 10 % of 3815) opted for self-sampling in comparison with undergoing a cervical screening test (CST) at the GP practice (n = 197, 5 %, x

Indexed as

Cervical cancer screeningCervical screening uptake rateCervical smear testing non-responderCervix unscreened women in Dumfries and GallowayCIN, Cervical intraepithelial neoplasiaCST, Cervical screening testGP, General practiceHPV, Human papillomavirusHuman papillomavirusLBC, Liquid-based cytologyNational Health Service ScotlandNHS, National Health ServicePCR, Polymerase chain reactionScreening overdueSelf-collection kitSS, Self-samplingVaginal self-sampling for HPV screening

Identifiers

PMID36161116
PMCPMC9502330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.